Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro

International Journal of Molecular Medicine

Volumn 18, Issue 6, 2006, Pages 1107-1112

  Spinazzi, Raffaella ^a   Albertin, Giovanna ^a   Nico, Beatrice ^b   Guidolin, Diego ^a   Di Liddo, Rosa ^a   Rossi, Gian Paolo ^a   Ribatti, Domenico ^b   Nussdorfer, Gastone G ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Angiogenesis; Endothelial cells; Palosuran; Rat; Urotensin receptors; Urotensin II

Indexed keywords

G PROTEIN COUPLED RECEPTOR; UROTENSIN; UROTENSIN II;

ANGIOGENESIS; ANIMAL; ARTICLE; BRAIN; CELL CULTURE; CELL DIVISION; CHICK EMBRYO; CHORIOALLANTOIS; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; IN VITRO STUDY; MALE; METABOLISM; PHYSIOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TIME; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; BRAIN; CELL DIVISION; CELLS, CULTURED; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; IMMUNOHISTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; UROTENSINS;

EID: 34249799747     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.18.6.1107     Document Type: Article

References (37)

1. Pearson D, Shively JE, Clark BR, Geschwind II, Barkley M, Nishioka RS and Bern HA: Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc Natl Acad Sci USA 77: 5021-5024, 1980.
2. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, McNulty DE, Ellis CE, Elshourbagy NA, Shabon U, Trill JJ, Hay DWP, Ohlstein EM, Bergsma DJ and Douglas SA: Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR 14. Nature 401: 282-286, 1999.
3. Douglas SA and Ohlstein EH: Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as therapeutic target for the management of cardiovascular disease. Trends Cardiovasc Med 10: 229-237, 2000.
4. Liu Q, Pong SS, Zeng Z, Zhang Q, Howard AD, Williams DR, Davidoff M, Wang R, Austin CP, McDonald TP, Bai C, George SR, Evans JF and Caskey CT: Identification of urotensin II as the endogenous ligand for the orphan G-protein coupled receptor GPR 14. Biochem Biophys Res Commun 266: 174-178, 1999.
5. Mori M, Sugo T, Abe M, Shimomura Y, Kurihara M, Kitada C, Kikuchi K, Shintari Y, Kurokawa T, Onda H, Nishimura O and Fujino M: Urotensin II is the endogenous ligand of a G-protein coupled orphan receptor, SENR (GPR14). Biochem Biophys Res Commun 265: 123-129, 1999.
6. Davenport AP and Maguire JJ: Urotensin II: fish neuropeptide catches orphan receptor. Trends Pharmacol Sci 21: 80-92, 2000.
7. Nothacker HP, Wang Z, McNeill AM, Saito Y, Marten S, O'Dowd B, Duckles SP and Civelli O: Identification of the natural ligand of an orphan G-protein coupled receptor involved in the regulation of vasoconstriction. Nat Cell Biol 1: 383-385, 1999. (Pubitemid 129493582)
8. Maguire JJ, Kuc RE and Davenport AP: Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 131: 441-446, 2000.
9. Matsushita M, Shichiri M, Imai T, Iwashina M, Tanaka H, Takasu N and Hirata Y: Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J Hypertens 19: 2185-2190, 2001. (Pubitemid 33135240)
10. Totsune K, Takahashi K, Arihara Z, Sone M, Satoh F, Ito S, Kimura Y, Sasano H and Murakami O: Role of urotensin II in patients on dialysis. Lancet 358: 810-811, 2001.
11. Yoshimoto T, Matsushita M and Hirata Y: Role of urotensin II in peripheral tissue as an autocrine/paracrine growth factor. Peptides 25: 1775-1781, 2004.
12. Cheung BMY, Leung R, Man YB and Wong LYF: Plasma concentration of urotensin II is raised in hypertension. J Hypertens 22: 1341-1344, 2004.
13. Russell FD and Molenaar P: Cardiovascular actions of human urotensin II: considerations for hypertension. Naunyn Schmiedebergs Arch Pharmacol 369: 271-273, 2004.
14. Douglas SA, Tayara L, Ohlstein EH, Halawa N and Giaid A: Congestive heart failure and expression of myocardial urotensin II. Lancet 359: 1990-1997, 2002.
15. Clozel M, Binkert C, Birker-Robaczewska M, Boukhadra C, Ding SS, Fischli W, Hess P, Mathys B, Morrison K, Müller C, Müller C, Nayler O, Qiu C, Rey M, Scherz NW, Velker J, Weller T, Xi JF and Ziltener P: Pharmacology of the urotensin- II receptor antagonist Palosuran (ACT-058362; 1-[2-(4-benzyl- 4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin system. J Pharmacol Exp Ther 311: 204-212, 2004.
16. Abbott NJ, Hughes CCW, Revest PA and Greenwood J: Development and characterization of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier. J Cell Sci 103: 23-37, 1992.
17. Baiguera S, Conconi MT, Guidolin D, Mazzocchi G, Malendowicz LK, Parnigotto PP, Spinazzi R and Nussdorfer GG: Ghrelin inhibits in vitro angiogenic activity of rat brain microvascular endothelial cells. Int J Mol Med 14: 849-854, 2004.
18. Folin M, Baiguera S, Tommasini M, Guidolin D, Conconi MT, De Carlo E, Nussdorfer GG and Parnigotto PP: Effects of β-amyloid on rat neuromicrovascular endothelial cells cultured in vitro. Int J Mol Med 15: 929-935, 2005.
19. Albertin G, Carraro G and Nussdorfer GG: Human adrenomedullin gene silencing by short interfering RNAs: A preliminary study. Int J Mol Med 15: 579-583, 2005.
20. Andreis PG, Rucinski M, Neri G, Conconi MT, Petrelli L, Parnigotto PP, Malendowicz LK and Nussdorfer GG: Neuropeptides B and W enhance the growth of human adrenocortical carcinoma-derived NCI-H295 cells by exerting MAPK p42/p44-mediated proliferogenic and antiapoptotic effects. Int J Mol Med 16: 1021-1028, 2005.
21. Rucinski M, Andreis PG, Ziolkowska A, Nussdorfer GG and Malendowicz LK: Differential expression and function of beacon in the rat adrenal cortex and medulla. Int J Mol Med 16: 35-40, 2005.
22. Albertin G, Carraro G, Petrelli L, Guidolin D, Neri G and Nussdorfer GG: Endothelin-1 and adrenomedullin enhance the growth of human adrenocortical carcinoma-derived SW-13 cell line by stimulating proliferation and inhibiting apoptosis. Int J Mol Med 15: 469-474, 2005.
23. Albertin G, Rucinski M, Carraro G, Forneris M, Andreis PG, Malendowicz LK and Nussdorfer GG: Adrenomedullin and vascular endothelium growth factor genes are overexpressed in the regenerating rat adrenal cortex, and AM and VEGF reciprocally enhance their mRNA expression in cultured rat adrenocortical cells. Int J Mol Med 16: 431-435, 2005.
24. Spinazzi R, Ziolkowska A, Neri G, Nowak M, Rebuffat P, Nussdorfer GG, Andreis PG and Malendowicz LK: Orexins modulate the growth of cultured rat adrenocortical cell, acting through type 1 and type 2 receptors coupled to the MAPK p42/p44- and p38-dependent cascades. Int J Mol Med 15: 847-852, 2005.
25. Rossi GP, Sticchi D, Giuliani L, Bernante P, Zavattiero S, Pessina AC and Nussdorfer GG: Adiponectin receptor expression in the human adrenal cortex and aldosterone-producing adenomas. Int J Mol Med 17: 975-980, 2006.
26. Belloni AS, Guidolin D, Salmaso R, Bova S, Rossi GP and Nussdorfer GG: Adrenomedullin, ANP and BNP are colocalized in a subset of endocrine cells in the rat heart. Int J Mol Med 15: 567-571, 2005.
27. Ribatti D, Guidolin D, Conconi MT, Nico B, Baiguera S, Parnigotto PP, Vacca A and Nussdorfer GG: Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo. Oncogene 22: 6458-6461, 2003.
28. Ribatti D, Gualandris A, Bastaki M, Vacca A, Iurlaro M, Roncali L and Presta M: New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay. J Vasc Res 34: 455-463, 1997. (Pubitemid 28008032)
29. Ribatti D, Vacca A and Presta M: The discovery of angiogenic factors: a historical review. Gen Pharmacol 35: 227-231, 2002. (Pubitemid 34215114)
30. Albertin G, Casale V, Ziolkowska A, Spinazzi R, Malendowicz LK, Rossi GP and Nussdorfer GG: Urotensin-II and UII-receptor expression and function in the rat adrenal cortex. Int J Mol Med 17: 1111-1115, 2006.
31. Kedzierski RM and Yanagisawa M: Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol 41: 851-876, 2001.
32. Lopez J and Martinez A: Cell and molecular biology of the multifunctional peptide adrenomedullin. Int Rev Cytol 221: 1-92, 2002.
33. Salani D, Taraboletti G, Rosanò L, Di Castro V, Borsotti P, Giavazzi R and Bagnato A: Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol 157: 1703-1711, 2000.
34. Nagaya N, Mori H, Murakami S, Kangawa K and Kitamura S: Adrenomedullin: angiogenesis and gene therapy. Am J Physiol 288: 1432-1437, 2005.
35. Bagnato A and Spinella F: Emerging role of endothelin-1 in tumor angiogenesis. Trends Endocrinol Metab 14: 44-50, 2002. (Pubitemid 36733931)
36. Nikitenko LL, Fox SB, Kehoe S, Rees MCP and Bicknell R: Adrenomedullin and tumor angiogenesis. Br J Cancer 94: 1-7, 2006.
37. Behm DJ, Herold CL, Ohlstein EH, Knight SD, Dhanak D and Douglas SA: Pharmacological characterization of SB-710411 (Cpa-c[D-Cys-Pal-D-Trp-Lys-Val- Cys]-Cpa-amide), a novel peptidic urotensin-II receptor antagonist. Br J Pharmacol 137: 449-458, 2002. (Pubitemid 35221898)